Delivering powdered, needle-free vaccines.

Delivering DNA and RNA Vaccines Where and How They Are Needed.

INTRODUCING ORLANCE MACH-1 ™​

LOW-DOSE, NEEDLE-FREE POWDERED NUCLEIC ACID VACCINES WITHOUT COLD CHAIN REQUIREMENTS.

Orlance aims to deliver powdered, needle-free, shelf-stable, nucleic acid vaccines (DNA and/or RNA) with its epidermal vaccine delivery platform.

Meet Us At:

Fierce J.P. Morgan Virtual Conference
16 to 18 January, 2024.

World Vaccine Congress, Washington DC
1 to 4 April, 2024.

Careers

Thank you for your interest in joining the Orlance team. While we currently do not have any openings, please check again another time.

Contact